BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36828628)

  • 1. Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences.
    Marchette RCN; Carlson ER; Frye EV; Hastings LE; Vendruscolo JCM; Mejias-Torres G; Lewis SJ; Hampson A; Volkow ND; Vendruscolo LF; Koob GF
    J Pharmacol Exp Ther; 2023 May; 385(2):117-134. PubMed ID: 36828628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fentanyl depression of respiration: Comparison with heroin and morphine.
    Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G
    Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
    Elder HJ; Walentiny DM; Beardsley PM
    Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventilatory Effects of Fentanyl, Heroin, and
    Hiranita T; Ho NP; France CP
    J Pharmacol Exp Ther; 2024 Jan; 388(2):244-256. PubMed ID: 37739803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating α4β2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats.
    Ren J; Ding X; Greer JJ
    Anesthesiology; 2019 Jun; 130(6):1017-1031. PubMed ID: 31008764
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hiranita T; Ho NP; France CP
    J Pharmacol Exp Ther; 2024 Feb; ():. PubMed ID: 38409115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of respiratory sensitivity and tolerance to the mu-opioid agonist fentanyl in rat.
    Laferrière A; Colin-Durand J; Moss IR
    Brain Res Dev Brain Res; 2005 May; 156(2):210-7. PubMed ID: 16099308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xylazine effects on opioid-induced brain hypoxia.
    Choi S; Irwin MR; Kiyatkin EA
    Psychopharmacology (Berl); 2023 Jul; 240(7):1561-1571. PubMed ID: 37340247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl.
    Kiyatkin EA
    Neuropharmacology; 2019 Jun; 151():219-226. PubMed ID: 30735692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
    Lewanowitsch T; Miller JH; Irvine RJ
    Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.
    Miner NB; Schutzer WE; Zarnegarnia Y; Janowsky A; Torralva R
    Drug Alcohol Depend; 2021 Oct; 227():108974. PubMed ID: 34492557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
    Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
    J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.
    Kuo A; Wyse BD; Meutermans W; Smith MT
    Br J Pharmacol; 2015 Jan; 172(2):532-48. PubMed ID: 24641546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to Opioid-Induced Respiratory Depression in Chronic High-Dose Opioid Users: A Model-Based Comparison With Opioid-Naïve Individuals.
    Algera MH; Olofsen E; Moss L; Dobbins RL; Niesters M; van Velzen M; Groeneveld GJ; Heuberger J; Laffont CM; Dahan A
    Clin Pharmacol Ther; 2021 Mar; 109(3):637-645. PubMed ID: 32865832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats.
    Crowley ML; Restrepo LF; Gamez-Jimenez LR; Patel A; Braun T; Pallares VLC; Ho NP; Reeves ME; McCurdy CR; McMahon LR; Hiranita T
    J Pharmacol Toxicol Methods; 2021; 111():107101. PubMed ID: 34242797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.
    Torralva R; Janowsky A
    J Pharmacol Exp Ther; 2019 Nov; 371(2):453-475. PubMed ID: 31492824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methocinnamox Reverses and Prevents Fentanyl-Induced Ventilatory Depression in Rats.
    Jimenez VM; Castaneda G; France CP
    J Pharmacol Exp Ther; 2021 Apr; 377(1):29-38. PubMed ID: 33431611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB
    Zavala CA; Thomaz AC; Iyer V; Mackie K; Hohmann AG
    Cannabis Cannabinoid Res; 2021 Oct; 6(5):389-400. PubMed ID: 33998863
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged ethanol administration prevents the development of tolerance to morphine-induced respiratory depression.
    Hill R; Roberts J; Maclachlan J; Dewey W; Kelly E; Henderson G
    Drug Alcohol Depend; 2019 Dec; 205():107674. PubMed ID: 31715438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.